complement factor I
Last updated 18 Aug 2020
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The CFI gene provides instructions for making a protein called complement factor I. This protein helps regulate a part of the body's immune response known as the complement system. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger inflammation, and remove debris from cells and tissues. This system must be carefully regulated so it targets only unwanted materials and does not attack the body's healthy cells. Complement factor I and several related proteins protect healthy cells by preventing activation of the complement system when it is not needed.
Video picks for GenesVideo library
Normal function
The CFI gene provides instructions for making a protein called complement factor I. This protein helps regulate a part of the body's immune response known as the complement system. The complement system is a group of proteins that work together to destroy foreign invaders (such as bacteria and viruses), trigger inflammation, and remove debris from cells and tissues. This system must be carefully regulated so it targets only unwanted materials and does not attack the body's healthy cells. Complement factor I and several related proteins protect healthy cells by preventing activation of the complement system when it is not needed.
Conditions referring to this gene or chromosome
Other names
AHUS3
C3b-INA
C3b-inactivator
C3B/C4B inactivator
C3BINA
CFAI_HUMAN
complement component I
complement control protein factor I
complement factor I heavy chain
complement factor I preproprotein
FI
IF
KAF
Konglutinogen-activating factor
light chain of factor I
Patient picks for Genes

Treatment and medication
Complementary and alternative medicine
Complementary and alternative medicine (CAM) is used by many people. It can have a very good effect on improving well-being and may be helpful in relieving some symptoms. However, although there is some evidence from clinical studies that CAMs may work for certain symptoms, the evidence is not very strong and it is impossible to draw firm conclusions about the benefits of each treatment. It is very important to consider whether any CAM treatment may have side-effects. Again the side-effects of some CAM treatments, particularly some herbal remedies, are not as well known as for conventional medicines. In addition, choosing to use alternative medicine instead of medically recommended treatments can sometimes be dangerous.
by Dr Hayley Willacy, FRCGP

Cancer
Breast cancer facts and risk factors
Most cases of breast cancer occur by chance. However, breast cancer does occur more often than usual in some families because of their genetic makeup.
by Dr Colin Tidy, MRCGP

Treatment and medication
What factors are causing antimicrobial resistance?
Following a recent study by health economists at the University of Manchester and the University of Southern Denmark, the tremendous pressure GPs are currently working under has been linked to increasing broad-spectrum antibiotic prescribing in England. Because excess antibiotic prescribing has been closely linked to antibiotic resistance, there are concerns that these higher prescribing levels may be contributing to antimicrobial resistance.
by Emily Jane Bashforth

Heart health and blood vessels
Dilated cardiomyopathy causes: what are the risk factors?
Having dilated cardiomyopathy means that your heart muscle is weakened, which affects how your heart pumps blood around your body. There are a wide range of dilated cardiomyopathy causes, including genetics, other health conditions, alcohol consumption and a poor diet. While we can't control some of these risk factors, we can make positive lifestyle changes to reduce our risk of developing dilated cardiomyopathy.
by Amberley Davis
Preventative health
Looking at the Moon
Feet are wider than hip distance and toes are slightly pointed out. Both arms lift as you turn from the waist to lift your arms and look at the moon behind you; as you do so the back heel can lift. As you inhale, lower your arms and come back to centre. I like to imagine that I can carry the light of the moon across the still waters of a lake. This form with its deep back rotation is linked with the water element and its associated organ and meridian system of the kidneys.

Type 1 diabetes
Is type 1 diabetes hereditary?
Dr Partha Kar Although type 1 diabetes is not an inherited disease, there is some genetic factor. A first-degree relative (sister, brother, son, daughter) of someone with type 1 diabetes has about a 1 in 16 chance of developing type 1 diabetes. For more information on type 1 diabetes, go to [https://patient.info/health/type-1-diabetes](https://patient.info/health/type-1-diabetes)
by Dr Partha Kar, FRCP
Related patient information and medicines

Patient information leaflet
Anticoagulants
In 2021, the UK's National Institute for Health and Care Excellence (NICE) recommended that DOACs should be the preferred option for AF, instead of warfarin. There are 13 known clotting factors which are called by their Roman numbers - factor I to factor XIII. A complex cascade of chemical reactions involving these ... The final step of this.

Patient information leaflet
Vitamin B12 deficiency and pernicious anaemia
What causes vitamin B12 deficiency. Pernicious anaemia Normally, when you eat foods with vitamin B12, the vitamin combines with a protein called intrinsic factor in the stomach. Intrinsic factor is essential to absorb vitamin b12 into the body. Symptoms may get worse initially during treatment. How much vitamin B12 do I need per day to avoid.

Patient information leaflet
Blood clotting tests
Blood clotting tests are used to diagnose and assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. There are 13 known clotting factors which are called by their Roman numbers - factor I to factor XIII. Next to a cut a complex series of reactions involving these clotting factors then ha... The final.

Patient information leaflet
Haemophilia
Haemophilia is a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding. Haemophilia is a condition where there is a deficiency of clotting factors, so people with this condition usually have.

Patient information leaflet
Can I take Ciprofloxacin and Doxycycline together?
Taking ciprofloxacin and doxycycline together may slightly increase the risk of side effects, such as skin sensitivity to sunlight or digestive upset. ...your prescriptions, over-the-counter medicines, and supplements are safe to take togetherAlways consult your GP, pharmacist, or another qualified healthcare professional before making decisions.

Patient information leaflet
Can I take Apixaban and Bisoprolol together?
There is no direct interaction between apixaban and bisoprolol. They work in different ways and do not interfere with how the body processes each other. Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Bisoprolol is a beta-blocker that slows the heart rate and lowers blood.
Further reading and references
- complement factor I; MedlinePlus, National Library of Medicine.
- Baracho GV, Nudelman V, Isaac L. Molecular characterization of homozygous hereditary factor I deficiency. Clin Exp Immunol. 2003 Feb;131(2):280-6. doi: 10.1046/j.1365-2249.2003.02077.x.
- Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009 Jan;17(1):100-4. doi: 10.1038/ejhg.2008.140. Epub 2008 Aug 6.
- Kavanagh D, Richards A, Noris M, Hauhart R, Liszewski MK, Karpman D, Goodship JA, Fremeaux-Bacchi V, Remuzzi G, Goodship TH, Atkinson JP. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Mol Immunol. 2008 Jan;45(1):95-105. doi: 10.1016/j.molimm.2007.05.004. Epub 2007 Jun 26.
- Nilsson SC, Trouw LA, Renault N, Miteva MA, Genel F, Zelazko M, Marquart H, Muller K, Sjoholm AG, Truedsson L, Villoutreix BO, Blom AM. Genetic, molecular and functional analyses of complement factor I deficiency. Eur J Immunol. 2009 Jan;39(1):310-23. doi: 10.1002/eji.200838702.
- Ponce-Castro IM, Gonzalez-Rubio C, Delgado-Cervino EM, Abarrategui-Garrido C, Fontan G, Sanchez-Corral P, Lopez-Trascasa M. Molecular characterization of Complement Factor I deficiency in two Spanish families. Mol Immunol. 2008 May;45(10):2764-71. doi: 10.1016/j.molimm.2008.02.008. Epub 2008 Mar 28.
- Richard I. The genetic and molecular bases of monogenic disorders affecting proteolytic systems. J Med Genet. 2005 Jul;42(7):529-39. doi: 10.1136/jmg.2004.028118.
- Servais A, Fremeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grunfeld JP, Lesavre P, Noel LH, Fakhouri F. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet. 2007 Mar;44(3):193-9. doi: 10.1136/jmg.2006.045328. Epub 2006 Oct 3.
- Vyse TJ, Morley BJ, Bartok I, Theodoridis EL, Davies KA, Webster AD, Walport MJ. The molecular basis of hereditary complement factor I deficiency. J Clin Invest. 1996 Feb 15;97(4):925-33. doi: 10.1172/JCI118515.
- Vyse TJ, Spath PJ, Davies KA, Morley BJ, Philippe P, Athanassiou P, Giles CM, Walport MJ. Hereditary complement factor I deficiency. QJM. 1994 Jul;87(7):385-401.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

